NervGen Pharma's total assets for Q3 2024 were C$22.46M, a decrease of -19.47% from the previous quarter. TSE:NGEN total liabilities were C$13.28M for the fiscal quarter, a -13.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.